Repligen | RGEN - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Agilent USD 602M 32M 2025-12
Align Technology USD 123.72M 2.27M 2026-03
Bio Techne USD 95.6M 3.97M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Bruker USD 269.1M 53.2M 2026-03
Charles River Laboratories USD 133.95M 14.85M 2026-03
Danaher USD 1.79B 54M 2026-03
Dentsply International USD 259M 41M 2026-03
General Electric Aerospace USD 10.68B 605M 2026-03
Henry Schein USD 1.04B 111M 2026-03
Illumina USD 218M 22M 2026-03
IQVIA Holdings USD 3.64B 112M 2026-03
Mettler Toledo International USD 228.72M 37.91M 2026-03
Myriad Genetics USD 32.6M 2.6M 2026-03
OraSure Technologies USD 10.63M 4.11M 2026-03
Pacific Biosciences Of California USD 13.61M 7.16M 2026-03
Pfizer USD 4.51B 734M 2026-03
Repligen USD 34.66M 4.65M 2026-03
Revvity USD 169.68M 15.78M 2026-03
Standard Biotools USD 8.01M 2.6M 2026-03
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Waters USD 103.78M 11.95M 2025-12
West Pharmaceutical Services USD 252.3M 1.4M 2026-03